U.S. Complex & Chronic Condition Management Market (By Disease Type: Cardiovascular Diseases, Oncology, Musculoskeletal, Women’s Health/Fertility/Maternity, Chronic Obstructive Pulmonary Disease, Others; By Service: Consulting Service, Implementation Service, Education Service, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033


The U.S. complex & chronic condition management market size was valued at USD 4.56 billion in 2023 and is expected to be worth around USD 15.93 billion by 2033, with a registered CAGR of 13.32% during forecast period 2024 to 2033.

U.S. Complex and Chronic Condition Management Market Size 2024 to 2033

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

US witnessed a rapid surge in the adoption of the telehealth and chronic condition management services during the pandemic owing to the lockdown restrictions. Moreover, the risks of getting infected with the COVID-19 diseases forced people to stay at their homes. This situation increased the adoption of the chronic condition management solutions among the patients who are suffering from one or more chronic diseases. The telehealth services helped the patients to take good care of their health and avoid any negative consequences due to the delayed care.

Moreover, the growth of the telehealth and chronic care management was fueled by the presence of strong telecommunications and IT infrastructure. The majority of the population had access to smartphones and internet that boosted growth of the complex & chronic condition management market in US. This trend is expected to continue during the forecast period and the US & chronic condition market is expected to witness a rapid surge throughout the forecast period.

U.S. Complex & Chronic Condition Management Market Key Takeaways

  • By Services, the Implementation service segment has captured revenue share of around 42.98% in 2023.
  • By Services, the consulting services segment has accounted revenue share of around 34.63% in 2023.
  • By Disease Type, the cardiovascular diseases segment has held revenue share of 28.24% in 2023.
  • By Disease Type, the oncology segment has generated 25.10% revenue share in 2023.

U.S. Complex & Chronic Condition Management Market Growth Factors

Chronic condition means patients living with the chronic diseases for years and the affected cells progress over time. The chronic diseases are the major revenue contributors to the healthcare industry. Complex & chronic condition management is a program that helps the patients and the healthcare professionals to improve the healthcare services and improve the patient’s quality of life. The chronic condition management services provide support to the patients from different medical services. The proliferation of digital technologies has encouraged the development of the telehealth industry. The rapid adoption of the telehealth services among both the healthcare professionals and consumers is the primary driver of the US complex & chronic condition management market.

Around half of the US population is suffering from at least one chronic disease. The most prominent chronic diseases in US are cardiovascular diseases, cancer, COPD, diabetes, and musculoskeletal disorders. These chronic diseases are the major causes of death in US. The rising prevalence of various chronic diseases coupled with the increasing healthcare expenditure is estimated to spur the demand for the innovative and advanced complex & chronic condition management services.Growing geriatric population is another major factor that highly influences the market growth. The geriatric population in US is rapidly growing. Moreover, the old age people are more prone to the chronic diseases and tend to spend more on their health. Therefore, the growing geriatric population coupled with the rising healthcare expenditure is expected to significantly foster the market growth during the forecast period.

U.S. Complex & Chronic Condition Management Market Scope

Report Coverage Details
Market Size In 2023 USD 4.56 Billion
Growth Rate From 2024 to 2033 CAGR of 13.32%
Revenue Projection in 2032 USD 15.93 Billion
Base Year 2023
Forecast Period 2024 To 2033
Fastest Growing Market United State
Segments Covered Service, Disease Type, Region 
Companies Mentioned AllScripts, Siemens Healthineers, Koninklijke Philips N.V., Pegasystems, Inc., Cognizant TriZetto Software Group Inc., IBM Corporation, ScienceSoft USA, MINES & Associates, Inc., Healthcare at Home, Mediware Information Systems

 

Disease Type Insights

Cardiovascular diseases accounted for the largest market share at 28.24% in 2023, and this trend is expected to continue over the projected period. The increased prevalence of cardiovascular diseases in US is the primary contributor to the growth of the complex and chronic condition management market. The proliferation of the digital technologies and development of advanced software systems has enabled a systematic care delivery in the US healthcare sector, which helps the patients to avoid any exacerbations and complications. The complex and chronic condition management solution connects the patients devices like smartphones and tablets with the electronic health records (EHR) through an app installed in the patients’ device. This solutions analyses the cardiovascular health of the patient, processes the information, and provides alerts and notifications that helps in the timely diagnosis and treatment. The complex and chronic condition management solution and the mobile app serve as a crucial communication point between the caregiver and the patient.

U.S. Complex and Chronic Condition Management Market Share, By Disease Type, 2023 (%)

Chronic Obstructive Pulmonary Disease (COPD) are expected to witness maximum gains over the forecast period due to rising patient preference for the complex and chronic condition management services for the COPD condition management. Moreover, the rising prevalence of the COPD among the US population is boosting the growth. It is estimated that around 14.8 million adults in US have been diagnosed with COPD in 2020.

Service Insights

The implementation services segment dominated the complex and chronic condition management market in US. The telehealth service providers play a crucial role in connecting the patients and the care providers. The arrangements are done by the service providers when a patient requires visiting a clinic or a hospital to acquire therapies and tests. The increased prevalence of various chronic diseases that frequently requires implementation services has fostered the growth of this segment. The patients suffering from the diseases such as cancer, reproductive disorder, and musculoskeletal disorders regularly needs the in-person care for receiving various therapies and conduct tests. Therefore, the implementation services have captured a huge market share owing to its higher revenue generation.

U.S. Complex and Chronic Condition Management Market Share, By Service, 2023 (%)

The education services are expected to be the fastest-growing segment. The education services are necessary for various patients who are suffering from COPD and different musculoskeletal conditions. The necessity for gaining information regarding the management of certain health conditions is driving the growth of the education services. The health education service providers are increasingly adopting the digital technologies for reaching out to the consumers. The education services play a major role in the self-management of chronic conditions.

Key Developments

  • In 2020, Allscripts announced a definitive agreement to sell its CarePort Health business to WellSky Corp. CarePort solutions assist hundreds of hospitals and post-acute care providers to efficiently coordinate and transition patients through different settings of care.
  • In 2020, ScienceSoft received licenses in the United Arab Emirates to offer IT services, IT solutions and IT consultancy and opened its first Middle East office in the UAE. The Middle East launch solidifies ScienceSoft’s aspiration to tap into new markets and grow international presence.
  • Siemens Healthineers and KlinikumLippe GmbH (KLG) had entered into a ten-year technology partnership for all the healthcare provider’s locations. The contract covers delivery and maintenance of large imaging equipment and ultrasound units.

U.S. Complex & Chronic Condition Management Market Companies

  • AllScripts
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Pegasystems, Inc.
  • Cognizant TriZetto Software Group Inc.
  • IBM Corporation
  • ScienceSoft USA
  • MINES & Associates, Inc.
  • Healthcare at Home
  • Mediware Information Systems

Segments Covered in the Report

By Disease Type

  • Cardiovascular Diseases
  • Oncology
  • Musculoskeletal
  • Women’s Health/Fertility/Maternity
  • Chronic Obstructive Pulmonary Disease
  • Others

By Service

  • Consulting Service
  • Implementation Service
  • Education Service
  • Others

Frequently Asked Questions

What is the current size of U.S. complex and chronic condition management market?
The U.S. complex and chronic condition management market size was reached at USD 4.56 billion in 2023 and is predicted to surpass USD 15.93 billion by 2033.
What is the growth rate of U.S. complex and chronic condition management market?
The U.S. complex and chronic condition management market is expected t grow at a CAGR of 13.32% during forecast period 2024 to 2033.
Who are the major players operating in the U.S. complex and chronic condition management market?
The major players operating in the U.S. complex and chronic condition management market are AllScripts, Siemens Healthineers, Koninklijke Philips N.V., Pegasystems, Inc., Cognizant TriZetto Software Group Inc., IBM Corporation, ScienceSoft USA, MINES & Associates, Inc., Healthcare at Home, Mediware Information Systems.
Which are the services offered by US complex & chronic condition management market?
The services offered by US complex & chronic condition management market are consulting service, implementation service, education service, others.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 6000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample